Infection with the gram-negative E.Coli has been associated with tumor growth, progression and metastasis of non-small cell lung cancer, by promoting lipid synthesis through the TLR4/9 pathway and, also, by facilitating cancer stem cell properties through the TLR4/IL-33 pathway [51,52,53,54]. The gene discussed is IL33; the disease is cancer.